STREAMLINE HEALTH SOLUTIONS (STRM) Fundamental Analysis & Valuation

NASDAQ:STRM • US86323X2053

Current stock price

5.3332 USD
-0.01 (-0.13%)
Last:

This STRM fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

1

1. STRM Profitability Analysis

1.1 Basic Checks

  • In the past year STRM has reported negative net income.
  • STRM had a negative operating cash flow in the past year.
  • STRM had negative earnings in 4 of the past 5 years.
  • STRM had a negative operating cash flow in each of the past 5 years.
STRM Yearly Net Income VS EBIT VS OCF VS FCFSTRM Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 5M -5M -10M -15M

1.2 Ratios

  • STRM has a Return On Assets (-25.30%) which is comparable to the rest of the industry.
  • STRM's Return On Equity of -82.00% is on the low side compared to the rest of the industry. STRM is outperformed by 69.44% of its industry peers.
Industry RankSector Rank
ROA -25.3%
ROE -82%
ROIC N/A
ROA(3y)-30.62%
ROA(5y)-20.25%
ROE(3y)-71.39%
ROE(5y)-46.33%
ROIC(3y)N/A
ROIC(5y)N/A
STRM Yearly ROA, ROE, ROICSTRM Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 -20 -40 -60 -80

1.3 Margins

  • STRM has a Gross Margin (48.29%) which is comparable to the rest of the industry.
  • In the last couple of years the Gross Margin of STRM has declined.
  • The Profit Margin and Operating Margin are not available for STRM so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 48.29%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-2.74%
GM growth 5Y-3.21%
STRM Yearly Profit, Operating, Gross MarginsSTRM Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 50 -50

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

1

2. STRM Health Analysis

2.1 Basic Checks

  • STRM does not have a ROIC to compare to the WACC, probably because it is not profitable.
  • Compared to 1 year ago, STRM has more shares outstanding
  • STRM has less shares outstanding than it did 5 years ago.
  • The debt/assets ratio for STRM is higher compared to a year ago.
STRM Yearly Shares OutstandingSTRM Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 10M 20M 30M 40M 50M
STRM Yearly Total Debt VS Total AssetsSTRM Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 20M 40M 60M

2.2 Solvency

  • STRM has an Altman-Z score of -5.15. This is a bad value and indicates that STRM is not financially healthy and even has some risk of bankruptcy.
  • STRM has a worse Altman-Z score (-5.15) than 75.00% of its industry peers.
  • A Debt/Equity ratio of 0.18 indicates that STRM is not too dependend on debt financing.
  • With a Debt to Equity ratio value of 0.18, STRM perfoms like the industry average, outperforming 50.00% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 0.18
Debt/FCF N/A
Altman-Z -5.15
ROIC/WACCN/A
WACC10.21%
STRM Yearly LT Debt VS Equity VS FCFSTRM Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 10M 20M 30M

2.3 Liquidity

  • A Current Ratio of 0.27 indicates that STRM may have some problems paying its short term obligations.
  • STRM has a worse Current ratio (0.27) than 91.67% of its industry peers.
  • STRM has a Quick Ratio of 0.27. This is a bad value and indicates that STRM is not financially healthy enough and could expect problems in meeting its short term obligations.
  • Looking at the Quick ratio, with a value of 0.27, STRM is doing worse than 91.67% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 0.27
Quick Ratio 0.27
STRM Yearly Current Assets VS Current LiabilitesSTRM Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 5M 10M 15M 20M

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

1

3. STRM Growth Analysis

3.1 Past

  • STRM shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -127.84%.
  • Looking at the last year, STRM shows a very negative growth in Revenue. The Revenue has decreased by -14.88% in the last year.
  • STRM shows quite a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 8.60% yearly.
EPS 1Y (TTM)-127.84%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%43.52%
Revenue 1Y (TTM)-14.88%
Revenue growth 3Y0.99%
Revenue growth 5Y8.6%
Sales Q2Q%11.09%

3.2 Future

  • No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
  • No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next Y15.38%
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year4.04%
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

  • No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
  • No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
STRM Yearly Revenue VS EstimatesSTRM Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 5M 10M 15M 20M 25M
STRM Yearly EPS VS EstimatesSTRM Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 -2 -4 -6 -8

More info and screens

Find the best growth stocksShow best growing peers

0

4. STRM Valuation Analysis

4.1 Price/Earnings Ratio

  • The Price/Earnings Ratio is negative for STRM. In the last year negative earnings were reported.
  • Also next year STRM is expected to report negative earnings again, which makes the also the Forward Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A
STRM Price Earnings VS Forward Price EarningsSTRM Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 20 -20 40 -40

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
STRM Per share dataSTRM EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 2 -2 4

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

0

5. STRM Dividend Analysis

5.1 Amount

  • No dividends for STRM!.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

Find the best dividend stocksShow peers with best dividend

STRM Fundamentals: All Metrics, Ratios and Statistics

STREAMLINE HEALTH SOLUTIONS

NASDAQ:STRM (8/11/2025, 8:05:02 PM)

5.3332

-0.01 (-0.13%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Technology
Earnings (Last)06-16
Earnings (Next)09-09
Inst Owners26.05%
Inst Owner Change-100%
Ins Owners17.45%
Ins Owner Change0%
Market Cap23.25M
Revenue(TTM)18.38M
Net Income(TTM)-9.06M
Analysts82.86
Price TargetN/A
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)0%
EPS NY rev (3m)0%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0%
Revenue NY rev (3m)0%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 1.27
P/FCF N/A
P/OCF N/A
P/B 2.1
P/tB N/A
EV/EBITDA N/A
EPS(TTM)-2.23
EYN/A
EPS(NY)-0.11
Fwd EYN/A
FCF(TTM)-0.49
FCFYN/A
OCF(TTM)-0.29
OCFYN/A
SpS4.22
BVpS2.54
TBVpS-3.9
PEG (NY)N/A
PEG (5Y)N/A
Graham Number0 (-100%)
Profitability
Industry RankSector Rank
ROA -25.3%
ROE -82%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 48.29%
FCFM N/A
ROA(3y)-30.62%
ROA(5y)-20.25%
ROE(3y)-71.39%
ROE(5y)-46.33%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-2.74%
GM growth 5Y-3.21%
F-Score4
Asset Turnover0.51
Health
Industry RankSector Rank
Debt/Equity 0.18
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 17.98%
Cap/Sales 4.67%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 0.27
Quick Ratio 0.27
Altman-Z -5.15
F-Score4
WACC10.21%
ROIC/WACCN/A
Cap/Depr(3y)33.38%
Cap/Depr(5y)45.96%
Cap/Sales(3y)6.59%
Cap/Sales(5y)8.9%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-127.84%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%43.52%
EPS Next Y15.38%
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)-14.88%
Revenue growth 3Y0.99%
Revenue growth 5Y8.6%
Sales Q2Q%11.09%
Revenue Next Year4.04%
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y15.23%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year135.97%
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y71.78%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y77.63%
OCF growth 3YN/A
OCF growth 5YN/A

STREAMLINE HEALTH SOLUTIONS / STRM Fundamental Analysis FAQ

What is the fundamental rating for STRM stock?

ChartMill assigns a fundamental rating of 1 / 10 to STRM.


What is the valuation status of STREAMLINE HEALTH SOLUTIONS (STRM) stock?

ChartMill assigns a valuation rating of 0 / 10 to STREAMLINE HEALTH SOLUTIONS (STRM). This can be considered as Overvalued.


How profitable is STREAMLINE HEALTH SOLUTIONS (STRM) stock?

STREAMLINE HEALTH SOLUTIONS (STRM) has a profitability rating of 0 / 10.


How financially healthy is STREAMLINE HEALTH SOLUTIONS?

The financial health rating of STREAMLINE HEALTH SOLUTIONS (STRM) is 1 / 10.


What is the expected EPS growth for STREAMLINE HEALTH SOLUTIONS (STRM) stock?

The Earnings per Share (EPS) of STREAMLINE HEALTH SOLUTIONS (STRM) is expected to grow by 15.38% in the next year.